Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lin-7 homolog B (LIN7B) is a member of the Lin-7/Velis/MALS family of polarity scaffold proteins first identified in _Caenorhabditis elegans_. LIN7B is a small PDZ-domain containing protein essential for assembling and maintaining the asymmetric distribution of receptors and ion channels in polarized cells[1][2][3]. It acts as a molecular scaffold, interacting with membrane proteins and other scaffold proteins (such as CASK) through its PDZ and L27 domains to form multiprotein complexes involved in basolateral membrane protein targeting[1][2][3]. In neurons, LIN7B is important for the trafficking and localization of NMDA receptors at synapses and may couple synaptic vesicle exocytosis to cell adhesion machinery[3]. This protein is not a direct drug target, receptor, transporter, or enzyme, but rather a structural organizer critical for proper membrane protein localization and signal transduction in neurons and epithelial cells[1][2][3]. Note: "lin-7 cell polarity scaffold B" refers to a protein family member rather than a therapeutic target; the correct molecular entity is "Lin-7 homolog B (LIN7B)".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lin-7 homolog B, crumbs cell polarity complex component (LIN7B).